Fig. 3From: Efficacy and safety of cangrelor as compared to ticagrelor in patients with ST-elevated myocardial infarction (STEMI): a systematic review and meta-analysisEffect of cangrelor vs. ticagrelor on the risks of all-cause mortality (A), bleeding (B) and thrombosis (C)Back to article page